Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed May 12, 2014 · 10-Q · 42 days after period end · 0001193125-14-194964
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Net Income | -$17.54M | -$12.95M | -$12.95M | -$1.42M |
| EPS Diluted | -$0.74 | -$0.85 | -$0.85 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end
